BICLUSTER_ID : UPREG-150
PATHOGENS /3/ : streptococcus pneumoniae,helicobacter pylori,ehrlichia chaffeensis
TARGETS /5/ : IL6, PTGS2, JUN, SERPINB2, PLAUR
Gene SetLeading Edge Genes
NETPATH IL 1 PATHWAY UPRHOB, BIRC3, JUN, CXCL1, NFKBIE, SERPINB2, NFKBIA, IL6, PTGS2, CXCL2, MYC
NETPATH IL 2 PATHWAY UPKLF6, DUSP5, JUN, GADD45G, PMAIP1, IL6, MYC, PLAUR, IER3
NCI IL6 7PATHWAYLMO4, IL6, CEBPD, JUN, JUNB, MYC
NETPATH IL 4 PATHWAY UPSTK17B, MXD1, JUN, IBRDC3, IL6, HSPB8, MYC, EGR2
GERY CEBP TARGETSGADD45B, CXCL1, EREG, JUNB, SERPINB2, GADD45G, ATF3, MAFK, PLAUR, BTG2
NETPATH IL 4 PATHWAY DOWNNFKBIA, IL6, GADD45B, GEM, PTGS2, CXCL2
NETPATH IL 7 PATHWAY UPCXCL1, JUN, CXCL2, MYC
NETPATH IL 6 PATHWAY UPMAFF, GADD45B, CXCL1, CEBPD, JUN, JUNB
GRAHAM NORMAL QUIESCENT VS NORMAL DIVIDING UP
NETPATH IL 9 PATHWAY UPJUNB, MYC
MAHAJAN RESPONSE TO IL1A UP
MARTORIATI MDM4 TARGETS NEUROEPITHELIUM UP
VARELA ZMPSTE24 TARGETS UP
CHEN LVAD SUPPORT OF FAILING HEART UP
LINDSTEDT DENDRITIC CELL MATURATION B
RASHI RESPONSE TO IONIZING RADIATION 2
LINDSTEDT DENDRITIC CELL MATURATION A
LIEN BREAST CARCINOMA METAPLASTIC VS DUCTAL UP
DACOSTA LOW DOSE UV RESPONSE VIA ERCC3 XPCS DN
ELVIDGE HYPOXIA UP
AMIT EGF RESPONSE 40 HELA
YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 5
JEON SMAD6 TARGETS UP
MITSIADES RESPONSE TO APLIDIN UP
THEILGAARD NEUTROPHIL AT SKIN WOUND UP
HEDVAT ELF4 TARGETS UP
HASINA NOL7 TARGETS UP
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION ERYTHROCYTE UP
MARTORIATI MDM4 TARGETS FETAL LIVER UP
LENAOUR DENDRITIC CELL MATURATION DN
HINATA NFKB TARGETS KERATINOCYTE UP
KOKKINAKIS METHIONINE DEPRIVATION 96HR UP
KEGG NOD LIKE RECEPTOR SIGNALING PATHWAY
DAZARD UV RESPONSE CLUSTER G3
OSADA ASCL1 TARGETS DN
DUTTA APOPTOSIS VIA NFKB
COULOUARN TEMPORAL TGFB1 SIGNATURE UP
PAL PRMT5 TARGETS DN
NCI MYC REPRESSPATHWAY
TSAI RESPONSE TO IONIZING RADIATION
DIRMEIER LMP1 RESPONSE EARLY
DER IFN GAMMA RESPONSE UP
NCI NFAT TFPATHWAY
ZHOU INFLAMMATORY RESPONSE LIVE UP
ONDER CDH1 TARGETS 3 DN
AMIT EGF RESPONSE 120 HELA
DANG REGULATED BY MYC DN
NIELSEN MALIGNAT FIBROUS HISTIOCYTOMA UP
WINTER HYPOXIA METAGENE
PARK TRETINOIN RESPONSE
MCLACHLAN DENTAL CARIES UP
GAJATE RESPONSE TO TRABECTEDIN UP
PODAR RESPONSE TO ADAPHOSTIN UP
BEGUM TARGETS OF PAX3 FOXO1 FUSION DN
TAVOR CEBPA TARGETS UP
FOSTER INFLAMMATORY RESPONSE LPS DN
GAURNIER PSMD4 TARGETS
KERLEY RESPONSE TO CISPLATIN UP
SATO SILENCED BY DEACETYLATION IN PANCREATIC CANCER
LAU APOPTOSIS CDKN2A UP
ZHOU INFLAMMATORY RESPONSE LPS UP
GESERICK TERT TARGETS DN
AMIT SERUM RESPONSE 120 MCF10A
NETPATH IL 3 PATHWAY DOWN
BROWNE HCMV INFECTION 2HR UP
BERENJENO TRANSFORMED BY RHOA UP
CORUM REL-MAP3K8-RELA-TNIP2-PAPOLA COMPLEX
SESTO RESPONSE TO UV C3
VERHAAK AML WITH NPM1 MUTATED UP
AMIT EGF RESPONSE 40 MCF10A
BROCKE APOPTOSIS REVERSED BY IL6
GEISS RESPONSE TO DSRNA UP
NCI P53DOWNSTREAMPATHWAY
ST TUMOR NECROSIS FACTOR PATHWAY
ZHOU INFLAMMATORY RESPONSE FIMA UP
CHASSOT SKIN WOUND
TIAN TNF SIGNALING VIA NFKB
LEE LIVER CANCER HEPATOBLAST
NAGASHIMA EGF SIGNALING UP
AMIT DELAYED EARLY GENES
AMIT EGF RESPONSE 60 MCF10A
HINATA NFKB TARGETS FIBROBLAST UP
NOJIMA SFRP2 TARGETS UP
CHEN HOXA5 TARGETS 6HR UP
MISSIAGLIA REGULATED BY METHYLATION UP
SMIRNOV CIRCULATING ENDOTHELIOCYTES IN CANCER UP
OSWALD HEMATOPOIETIC STEM CELL IN COLLAGEN GEL UP
NCI ATF2 PATHWAY
LEONARD HYPOXIA
SESTO RESPONSE TO UV C1
KYNG ENVIRONMENTAL STRESS RESPONSE NOT BY GAMMA IN OLD
CROONQUIST STROMAL STIMULATION UP
BERENJENO TRANSFORMED BY RHOA REVERSIBLY DN
HALMOS CEBPA TARGETS UP
ZHANG RESPONSE TO CANTHARIDIN UP
BOYLAN MULTIPLE MYELOMA C DN
SAGIV CD24 TARGETS DN
KHETCHOUMIAN TRIM24 TARGETS UP
KRIGE RESPONSE TO TOSEDOSTAT 24HR UP
GUTIERREZ WALDENSTROEMS MACROGLOBULINEMIA 1 DN
RUTELLA RESPONSE TO CSF2RB AND IL4 DN
MAHADEVAN RESPONSE TO MP470 DN
EHRLICH ICF SYNDROM DN
CHIARADONNA NEOPLASTIC TRANSFORMATION KRAS CDC25 DN
HARRIS HYPOXIA
NETPATH KIT RECEPTOR PATHWAY UP
SCHAVOLT TARGETS OF TP53 AND TP63
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS BLACK UP
CASORELLI ACUTE PROMYELOCYTIC LEUKEMIA UP
DEBIASI APOPTOSIS BY REOVIRUS INFECTION UP
KOKKINAKIS METHIONINE DEPRIVATION 48HR UP
NUNODA RESPONSE TO DASATINIB IMATINIB UP
AMIT EGF RESPONSE 20 HELA
BASSO CD40 SIGNALING UP
KAN RESPONSE TO ARSENIC TRIOXIDE
MUELLER METHYLATED IN GLIOBLASTOMA
SOUCEK MYC TARGETS
MARZEC IL2 SIGNALING UP
NAGASHIMA NRG1 SIGNALING UP
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 6HR DN
ZERBINI RESPONSE TO SULINDAC UP
SCIAN INVERSED TARGETS OF TP53 AND TP73 DN
BILBAN B CLL LPL DN
WU HBX TARGETS 2 DN
NETPATH B CELL RECEPTOR PATHWAY UP
MAHADEVAN RESPONSE TO MP470 UP
FERRARI RESPONSE TO FENRETINIDE UP
SHAFFER IRF4 MULTIPLE MYELOMA PROGRAM
BILD HRAS ONCOGENIC SIGNATURE
NETPATH IL 3 PATHWAY UP
LIANG SILENCED BY METHYLATION 2
DAUER STAT3 TARGETS UP
LEE LIVER CANCER ACOX1 UP
ELVIDGE HIF1A AND HIF2A TARGETS DN
WANG ESOPHAGUS CANCER PROGRESSION UP
WU HBX TARGETS 1 UP
AMIT EGF RESPONSE 60 HELA
ADDYA ERYTHROID DIFFERENTIATION BY HEMIN
BERENJENO TRANSFORMED BY RHOA FOREVER DN
KANNAN TP53 TARGETS UP
CHEN HOXA5 TARGETS 9HR UP
DAZARD UV RESPONSE CLUSTER G2
NCI CD40 PATHWAY
NETPATH IL 5 PATHWAY UPIRF2, BIRC3, DUSP5, NFKB2, NFKBIE, IER3, EGR2
AMIT SERUM RESPONSE 40 MCF10A
DASU IL6 SIGNALING SCAR DN
SEKI INFLAMMATORY RESPONSE LPS UP
GRAHAM CML QUIESCENT VS CML DIVIDING UP
CONCANNON APOPTOSIS BY EPOXOMICIN UP
ZHANG RESPONSE TO IKK INHIBITOR AND TNF UP
PARK TRETINOIN RESPONSE AND PML RARA FUSION
BIERIE INFLAMMATORY RESPONSE TGFB1
ENGELMANN CANCER PROGENITORS UP
SENESE HDAC1 AND HDAC2 TARGETS UP
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 3D DN
XU HGF TARGETS INDUCED BY AKT1 6HR
ONDER CDH1 TARGETS 2 DN
SENESE HDAC1 TARGETS UP
MANALO HYPOXIA UP
INGA TP53 TARGETS
HAHTOLA MYCOSIS FUNGOIDES CD4 UP
KIM WT1 TARGETS UP
SENESE HDAC3 TARGETS UP
UZONYI RESPONSE TO LEUKOTRIENE AND THROMBIN
XU HGF SIGNALING NOT VIA AKT1 6HR
BIOCARTA KERATINOCYTE PATHWAY
HESS TARGETS OF HOXA9 AND MEIS1 DN
DASU IL6 SIGNALING UP
ELVIDGE HYPOXIA BY DMOG UP
GRAHAM CML QUIESCENT VS NORMAL DIVIDING UP
OSWALD HEMATOPOIETIC STEM CELL IN COLLAGEN GEL DN
ZUCCHI METASTASIS DN
PRAMOONJAGO SOX4 TARGETS UP
WATTEL AUTONOMOUS THYROID ADENOMA DN
NCI TCRJNKPATHWAY
CORUM ETS2-FOS-JUN COMPLEX
PICCALUGA ANGIOIMMUNOBLASTIC LYMPHOMA DN
YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 1
ELVIDGE HIF1A TARGETS DN
Color legend
q-value10.20.050.010.0010.0001
Color
TABLE OF Q-VALUES
ehrlichia chaffeensis arkansahelicobacter pylori kx2 mgepstreptococcus pneumoniae tigr4GeneSet Name
0.00744 0.00000 0.00001NETPATH_IL_1_PATHWAY_UP
0.00029 0.04909 0.07061NETPATH_IL_2_PATHWAY_UP
0.00000 0.09551 0.00381NCI_IL6_7PATHWAY
0.00011 0.00426 0.00685NETPATH_IL_4_PATHWAY_UP
0.01308 0.00038 0.00001GERY_CEBP_TARGETS
0.00001 0.00009 0.01938NETPATH_IL_4_PATHWAY_DOWN
0.00034 0.00019 0.00009NETPATH_IL_7_PATHWAY_UP
0.00003 0.01969 0.00000NETPATH_IL_6_PATHWAY_UP
0.00021 0.00541 0.00058GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.00097 0.00202 0.05141NETPATH_IL_9_PATHWAY_UP
0.01198 0.00001 0.00006MAHAJAN_RESPONSE_TO_IL1A_UP
0.18807 0.13017 0.05839MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP
0.05834 0.00016 0.00000VARELA_ZMPSTE24_TARGETS_UP
0.14628 0.00040 0.00000CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP
0.00007 0.00000 0.00796LINDSTEDT_DENDRITIC_CELL_MATURATION_B
0.00307 0.00000 0.00000RASHI_RESPONSE_TO_IONIZING_RADIATION_2
0.00000 0.00000 0.15403LINDSTEDT_DENDRITIC_CELL_MATURATION_A
0.03933 0.02379 0.02026LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP
0.15676 0.15264 0.09613DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_DN
0.01170 0.00095 0.00000ELVIDGE_HYPOXIA_UP
0.03874 0.00053 0.00000AMIT_EGF_RESPONSE_40_HELA
0.00697 0.00313 0.00224YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5
0.00046 0.00000 0.11902JEON_SMAD6_TARGETS_UP
0.09988 0.00011 0.00323MITSIADES_RESPONSE_TO_APLIDIN_UP
0.01384 0.00010 0.00077THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP
0.05366 0.13156 0.05669HEDVAT_ELF4_TARGETS_UP
0.18351 0.01697 0.00656HASINA_NOL7_TARGETS_UP
0.00081 0.09686 0.07760TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP
0.19874 0.06503 0.00087MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP
0.00000 0.11818 0.02611LENAOUR_DENDRITIC_CELL_MATURATION_DN
0.00055 0.00000 0.00741HINATA_NFKB_TARGETS_KERATINOCYTE_UP
0.03945 0.14574 0.00726KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP
0.00013 0.00019 0.02561KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.03910 0.01539 0.03617DAZARD_UV_RESPONSE_CLUSTER_G3
0.00001 0.14030 0.09859OSADA_ASCL1_TARGETS_DN
0.00000 0.00000 0.00090DUTTA_APOPTOSIS_VIA_NFKB
0.11433 0.02721 0.02113COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP
0.01020 0.00255 0.02551PAL_PRMT5_TARGETS_DN
0.09624 0.18680 0.06003NCI_MYC_REPRESSPATHWAY
0.00169 0.00328 0.03596TSAI_RESPONSE_TO_IONIZING_RADIATION
0.00000 0.00124 0.00000DIRMEIER_LMP1_RESPONSE_EARLY
0.00007 0.03368 0.17933DER_IFN_GAMMA_RESPONSE_UP
0.03630 0.09081 0.00004NCI_NFAT_TFPATHWAY
0.01092 0.00000 0.00172ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP
0.02809 0.00020 0.00000ONDER_CDH1_TARGETS_3_DN
0.07404 0.00007 0.00000AMIT_EGF_RESPONSE_120_HELA
0.00130 0.13619 0.00565DANG_REGULATED_BY_MYC_DN
0.01021 0.00622 0.05863NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_UP
0.11984 0.00315 0.00002WINTER_HYPOXIA_METAGENE
0.00097 0.09790 0.10180PARK_TRETINOIN_RESPONSE
0.00000 0.00006 0.18322MCLACHLAN_DENTAL_CARIES_UP
0.02606 0.10731 0.00103GAJATE_RESPONSE_TO_TRABECTEDIN_UP
0.00428 0.00000 0.00000PODAR_RESPONSE_TO_ADAPHOSTIN_UP
0.01817 0.02749 0.19127BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN
0.00572 0.04908 0.01378TAVOR_CEBPA_TARGETS_UP
0.00000 0.00146 0.01424FOSTER_INFLAMMATORY_RESPONSE_LPS_DN
0.00000 0.00000 0.09452GAURNIER_PSMD4_TARGETS
0.06718 0.18636 0.00312KERLEY_RESPONSE_TO_CISPLATIN_UP
0.02810 0.15948 0.00028SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER
0.06604 0.01625 0.00272LAU_APOPTOSIS_CDKN2A_UP
0.00269 0.00059 0.05005ZHOU_INFLAMMATORY_RESPONSE_LPS_UP
0.00047 0.00002 0.00000GESERICK_TERT_TARGETS_DN
0.04018 0.00109 0.00000AMIT_SERUM_RESPONSE_120_MCF10A
0.01795 0.17911 0.18876NETPATH_IL_3_PATHWAY_DOWN
0.15614 0.00890 0.00000BROWNE_HCMV_INFECTION_2HR_UP
0.09965 0.15052 0.02776BERENJENO_TRANSFORMED_BY_RHOA_UP
0.10047 0.11696 0.11125CORUM_REL-MAP3K8-RELA-TNIP2-PAPOLA_COMPLEX
0.17152 0.00018 0.00000SESTO_RESPONSE_TO_UV_C3
0.00000 0.00145 0.01022VERHAAK_AML_WITH_NPM1_MUTATED_UP
0.06408 0.01511 0.00000AMIT_EGF_RESPONSE_40_MCF10A
0.00000 0.00158 0.00015BROCKE_APOPTOSIS_REVERSED_BY_IL6
0.00175 0.00000 0.03793GEISS_RESPONSE_TO_DSRNA_UP
0.07476 0.11095 0.00000NCI_P53DOWNSTREAMPATHWAY
0.00584 0.00008 0.10060ST_TUMOR_NECROSIS_FACTOR_PATHWAY
0.09979 0.00011 0.02569ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP
0.15171 0.00239 0.00000CHASSOT_SKIN_WOUND
0.00003 0.00000 0.00001TIAN_TNF_SIGNALING_VIA_NFKB
0.00021 0.10358 0.01752LEE_LIVER_CANCER_HEPATOBLAST
0.00040 0.00000 0.00000NAGASHIMA_EGF_SIGNALING_UP
0.11440 0.00009 0.00000AMIT_DELAYED_EARLY_GENES
0.02646 0.00000 0.00000AMIT_EGF_RESPONSE_60_MCF10A
0.00358 0.00009 0.00038HINATA_NFKB_TARGETS_FIBROBLAST_UP
0.01772 0.00000 0.00000NOJIMA_SFRP2_TARGETS_UP
0.01170 0.00788 0.00007CHEN_HOXA5_TARGETS_6HR_UP
0.00123 0.00396 0.05746MISSIAGLIA_REGULATED_BY_METHYLATION_UP
0.00021 0.06739 0.00812SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP
0.00488 0.00000 0.00000OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP
0.02314 0.00272 0.00028NCI_ATF2_PATHWAY
0.01232 0.00000 0.00001LEONARD_HYPOXIA
0.16308 0.00303 0.00117SESTO_RESPONSE_TO_UV_C1
0.16497 0.09677 0.14541KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_OLD
0.00000 0.05041 0.00000CROONQUIST_STROMAL_STIMULATION_UP
0.00044 0.04846 0.00179BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_DN
0.03101 0.03870 0.00000HALMOS_CEBPA_TARGETS_UP
0.12494 0.00028 0.05948ZHANG_RESPONSE_TO_CANTHARIDIN_UP
0.18326 0.12934 0.00574BOYLAN_MULTIPLE_MYELOMA_C_DN
0.00127 0.00458 0.00002SAGIV_CD24_TARGETS_DN
0.00000 0.12799 0.02288KHETCHOUMIAN_TRIM24_TARGETS_UP
0.02845 0.10597 0.16308KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP
0.15904 0.01011 0.00068GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_DN
0.00000 0.16288 0.07880RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN
0.18500 0.00005 0.00000MAHADEVAN_RESPONSE_TO_MP470_DN
0.00931 0.06524 0.03720EHRLICH_ICF_SYNDROM_DN
0.00000 0.10649 0.07890CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN
0.00160 0.00009 0.00000HARRIS_HYPOXIA
0.02531 0.00355 0.00001NETPATH_KIT_RECEPTOR_PATHWAY_UP
0.16319 0.11104 0.00046SCHAVOLT_TARGETS_OF_TP53_AND_TP63
0.18332 0.13289 0.02297GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP
0.01714 0.01398 0.00000CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP
0.00144 0.00012 0.00002DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP
0.01570 0.11555 0.00577KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP
0.09165 0.05677 0.15883NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP
0.00013 0.00435 0.00019AMIT_EGF_RESPONSE_20_HELA
0.00000 0.01278 0.01887BASSO_CD40_SIGNALING_UP
0.09168 0.00248 0.00024KAN_RESPONSE_TO_ARSENIC_TRIOXIDE
0.01499 0.13657 0.11195MUELLER_METHYLATED_IN_GLIOBLASTOMA
0.00003 0.00002 0.02991SOUCEK_MYC_TARGETS
0.00161 0.01784 0.01084MARZEC_IL2_SIGNALING_UP
0.00648 0.00000 0.00000NAGASHIMA_NRG1_SIGNALING_UP
0.17707 0.01992 0.04093TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN
0.07345 0.00100 0.00038ZERBINI_RESPONSE_TO_SULINDAC_UP
0.16431 0.01597 0.12713SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN
0.00034 0.12382 0.00001BILBAN_B_CLL_LPL_DN
0.02731 0.05716 0.00343WU_HBX_TARGETS_2_DN
0.01457 0.02676 0.14179NETPATH_B_CELL_RECEPTOR_PATHWAY_UP
0.00029 0.00001 0.05724MAHADEVAN_RESPONSE_TO_MP470_UP
0.00947 0.00002 0.00024FERRARI_RESPONSE_TO_FENRETINIDE_UP
0.14892 0.01650 0.02086SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM
0.00696 0.00132 0.00000BILD_HRAS_ONCOGENIC_SIGNATURE
0.00000 0.13629 0.00810NETPATH_IL_3_PATHWAY_UP
0.00001 0.00002 0.13850LIANG_SILENCED_BY_METHYLATION_2
0.01097 0.00008 0.00000DAUER_STAT3_TARGETS_UP
0.00152 0.16748 0.10301LEE_LIVER_CANCER_ACOX1_UP
0.06645 0.01194 0.01450ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN
0.08841 0.11710 0.03617WANG_ESOPHAGUS_CANCER_PROGRESSION_UP
0.02293 0.03293 0.00585WU_HBX_TARGETS_1_UP
0.05909 0.00000 0.00000AMIT_EGF_RESPONSE_60_HELA
0.02809 0.00073 0.00000ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN
0.00705 0.02345 0.00046BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN
0.12522 0.01451 0.00146KANNAN_TP53_TARGETS_UP
0.01709 0.00000 0.00003CHEN_HOXA5_TARGETS_9HR_UP
0.03944 0.00000 0.00000DAZARD_UV_RESPONSE_CLUSTER_G2
0.08348 0.00002 0.11127NCI_CD40_PATHWAY
0.00007 0.00002 0.00002NETPATH_IL_5_PATHWAY_UP
0.00705 0.00219 0.00000AMIT_SERUM_RESPONSE_40_MCF10A
0.15314 0.12988 0.18137DASU_IL6_SIGNALING_SCAR_DN
0.00000 0.00000 0.00000SEKI_INFLAMMATORY_RESPONSE_LPS_UP
0.00007 0.00677 0.00000GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP
0.06066 0.00000 0.00250CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP
0.00000 0.00000 0.00001ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP
0.00000 0.03379 0.14027PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION
0.03251 0.00543 0.00416BIERIE_INFLAMMATORY_RESPONSE_TGFB1
0.03879 0.05585 0.05987ENGELMANN_CANCER_PROGENITORS_UP
0.15854 0.00621 0.05989SENESE_HDAC1_AND_HDAC2_TARGETS_UP
0.00030 0.04410 0.15405TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN
0.03408 0.06063 0.05262XU_HGF_TARGETS_INDUCED_BY_AKT1_6HR
0.00757 0.01031 0.10479ONDER_CDH1_TARGETS_2_DN
0.09820 0.02102 0.08992SENESE_HDAC1_TARGETS_UP
0.07823 0.01569 0.13422MANALO_HYPOXIA_UP
0.02186 0.02719 0.00001INGA_TP53_TARGETS
0.00262 0.00008 0.00000HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP
0.13365 0.00000 0.00001KIM_WT1_TARGETS_UP
0.09963 0.04896 0.11682SENESE_HDAC3_TARGETS_UP
0.02814 0.00000 0.00000UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN
0.01646 0.00823 0.09671XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR
0.12303 0.04845 0.04968BIOCARTA_KERATINOCYTE_PATHWAY
0.00000 0.11528 0.00000HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN
0.14492 0.10056 0.00007DASU_IL6_SIGNALING_UP
0.04510 0.00024 0.00000ELVIDGE_HYPOXIA_BY_DMOG_UP
0.00001 0.00000 0.00000GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.00511 0.00000 0.00000OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN
0.10538 0.00076 0.00000ZUCCHI_METASTASIS_DN
0.07569 0.00000 0.00000PRAMOONJAGO_SOX4_TARGETS_UP
0.00144 0.18682 0.00001WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN
0.06897 0.09752 0.15598NCI_TCRJNKPATHWAY
0.05509 0.14593 0.05298CORUM_ETS2-FOS-JUN_COMPLEX
0.05114 0.00000 0.00000PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN
0.18992 0.00291 0.00069YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1
0.08874 0.00973 0.03264ELVIDGE_HIF1A_TARGETS_DN